10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD
10 years ago, in February 2007, the Towards a Revolution in COPD Health (TORCH) study was published in the New England Journal of Medicine [1]. While the objective of the study was to demonstrate a survival benefit of inhaled corticosteroids (ICS) in combination with long-acting beta-agonists (LABA) compared to placebo in chronic obstructive pulmonary disease (COPD), arguably the most lasting impact of the study on the field of COPD has been a progressive re-evaluation of the safety of ICS [1].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Chalmers, J. D., Keir, H. R. Tags: Respiratory infections and tuberculosis Editorials Source Type: research
More News: Chronic Obstructive Pulmonary | Corticosteroid Therapy | Respiratory Medicine | Study | Tuberculosis